Maximize Your Impact At Tech 4 Health 2026
Tech 4 Health 2026, taking place March 25 at Paris Expo Porte de Versailles, is one of Europe’s most targeted gatherings at the intersection of healthcare and technology. This annual conference attracts healthcare professionals, medical technology innovators, health system executives, digital health startups, and regulatory experts building the next generation of patient-centric solutions.
Attendees come with clear intent—evaluating biomedical platforms, forming partnerships for R&D, and sourcing digital health tools that improve outcomes, efficiency, and accessibility. Many are leaders with purchasing authority across hospital systems, research institutions, and public health agencies.
The enclosed attendee data helps surface key contacts by role, such as CIOs, Chief Medical Officers, Digital Strategy Leads, or Procurement Directors. Engaging early allows your team to align outreach with budget cycles, build rapport with the right decision-makers, and enter Paris with a pipeline already in motion.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Tech 4 Health attendees are focused on digital medicine, AI in diagnostics, telehealth delivery, and cross-border collaboration. Sales and marketing teams can use the Vendelux enriched conference attendee list to identify top prospects segmenting by organization type—hospital group, pharma, MedTech startup, or academic network—and by role, such as innovation lead or tech procurement.
Use attendee data to shape message relevance by focusing on real-world use cases that matter in healthcare: cost containment, data security, improved clinical workflows, or patient engagement. Outreach can be timed with buying seasons, especially for health institutions with fixed annual budgets.
This enriched attendee list makes it easier to book meetings in advance with those evaluating new technology, run demos on-site with qualified prospects, and maintain post-event momentum with personalized follow-ups based on shared interests discussed in Paris. It’s a proven way to increase meeting volume, build qualified pipeline, and convert event exposure into long-term partnerships.
Timing Is Everything
Tech 4 Health 2026 is scheduled for March 25, 2026. With healthcare planning and procurement often scoped in Q1, early outreach ensures you engage while departments are allocating spend. Use Vendelux in May 2025 to identify senior stakeholders set to attend and build trust ahead of the event.
Starting now helps teams create event-specific messaging, schedule 1:1 meetings, and qualify accounts that match strategic targets. Aligning against the enriched attendee list early lets your sales team reach the right people with the right message before competitor overload sets in closer to showtime.
What’s Included In The Tech 4 Health 2026 Attendee List?
Vendelux provides insight into executives expected at Tech 4 Health 2026 through organizer-sourced data and predictive modeling. Clients can upload a list of target companies to find matches within the attendee group and prioritize outreach accordingly.
The enriched attendee list includes first and last names, job titles, company names, company websites, cities, states, countries, LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is Tech 4 Health 2026?
The event will be held at Paris Expo Porte de Versailles in Paris, Île-de-France, France.
When Is Tech 4 Health 2026?
Tech 4 Health 2026 is scheduled for March 25, 2026.
What Type Of Event Is Tech 4 Health 2026?
Tech 4 Health 2026 is a healthcare technology conference focused on medical innovation, digital transformation, and operational efficiency within health systems. The event features live keynotes, product showcases, interactive panels, and structured networking opportunities.
How Many People Attend Tech 4 Health 2026?
Attendance is expected to include over 1,500 professionals from more than 30 countries. Most participants hold senior roles in clinical technology, health strategy, policy-making, hospital management, and medical R&D.
